← FDA DRUG APPROVALS

FDA ANDA · ANDA211282

FLUOXETINE

fluoxetine hydrochloride

Sponsor: SCIEGEN PHARMS

APPLICATION
ANDA211282
TYPE
ANDA
ORIGINAL APPROVAL
2019-01-10
LATEST ACTION
2024-01-09
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

FLUOXETINE HYDROCHLORIDEPrescription
FLUOXETINE HYDROCHLORIDE EQ 60MG BASE · TABLET · ORAL

Approval history

2024-01-09Labeling · Supplement 4 · standardAP
2024-01-09Labeling · Supplement 8 · standardAP
2019-01-10UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →